Hydroxyzine Bluefish (Hydroxyzine Hydrochloride)

Hydroxyzine is used to treat conditions mediated by histamine release in the allergic and dermatologic pathways.

• Allergic rhinitis: reduces nasal congestion, sneezing and itching.
• Pruritus: relieves skin itching associated with chronic urticaria or atopic dermatitis.
• Anxiety: provides short‑term anxiolytic effect for patients with acute anxiety.
• Sedation: induces calming effect useful before medical procedures.

• Hydroxyzine acts as a selective antagonist of peripheral H1 histamine receptors, preventing histamine‑induced vasodilation and increased vascular permeability. It also exhibits anticholinergic activity by blocking muscarinic receptors and penetrates the central nervous system, producing sedative and anxiolytic effects through inhibition of neuronal excitation. The combined antihistaminic and central actions underlie its therapeutic profile.

Hydroxyzine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Drowsiness: feeling of sleepiness or reduced alertness.
• Dry mouth: decreased salivation leading to thirst.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Blurred vision: temporary visual disturbances.
• Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm requiring medical attention.
• Severe allergic reaction: rash, swelling, or difficulty breathing (anaphylaxis).
• Hepatotoxicity: elevated liver enzymes indicating liver injury.
• Neuroleptic malignant syndrome: rare but life‑threatening condition with fever and muscle rigidity.

Before prescribing Hydroxyzine Bluefish, clinicians should consider several safety factors.

• Pregnancy: use only if potential benefit justifies risk, as safety data are limited.
• Elderly patients: monitor for increased sedation and anticholinergic effects.
• Driving: avoid operating machinery until individual response is known.
• Concomitant CNS depressants: use caution as additive sedation may occur.
• Liver impairment: dose adjustment may be required; monitor hepatic function.
• Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Hydroxyzine can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Alcohol: synergistic CNS depression leading to profound sedation.
• Opioids: enhanced respiratory depression and sedation.
• Anticholinergic drugs: increased risk of dry mouth, constipation, urinary retention.
• QT‑prolonging agents: additive effect on cardiac repolarization.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): may raise hydroxyzine plasma levels.
• CYP3A4 inducers (e.g., rifampicin): may reduce effectiveness.
• Other antihistamines: cumulative antihistaminic effect may increase drowsiness.
• Sedative antidepressants (e.g., trazodone): monitor for excessive sedation.